Decline in PSA levels was observed in 13/16 evaluable patients, and stable disease for 6 months was seen in 41.2% of patients 143
This improvement promotes ECM remodeling and helps prevent the pathological fibrosis associated with various eye diseases (Shan et al., 2023)
Brown E, Wilding JPH, Barber TM, Alam U, Cuthbertson DJ (2019) Weight loss variability with SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes mellitus and obesity: mechanistic possibilities
Patients with a history of allergic reactions or sensitivities to GLP-1 receptor agonists, pancreatitis, thyroid cancerincluding medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN-2) generally are not suitable candidates for this therapy
EVs marker proteins identified by Huang include tetraspanins, cytoplasmic proteins, Annexins, RABS, and cytoskeletal proteins (Huang et al